DD157614A5 - Verfahren zur herstellung von pyrimidyl-chinazolinen - Google Patents

Verfahren zur herstellung von pyrimidyl-chinazolinen Download PDF

Info

Publication number
DD157614A5
DD157614A5 DD81228589A DD22858981A DD157614A5 DD 157614 A5 DD157614 A5 DD 157614A5 DD 81228589 A DD81228589 A DD 81228589A DD 22858981 A DD22858981 A DD 22858981A DD 157614 A5 DD157614 A5 DD 157614A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
atoms
amino
alkyl
Prior art date
Application number
DD81228589A
Other languages
German (de)
English (en)
Inventor
Heinz Bender
Thomas Raabe
Helmut Bohn
Piero Martorana
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of DD157614A5 publication Critical patent/DD157614A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Catching Or Destruction (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DD81228589A 1980-03-27 1981-03-25 Verfahren zur herstellung von pyrimidyl-chinazolinen DD157614A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803011809 DE3011809A1 (de) 1980-03-27 1980-03-27 Pyrimidyl-chinazoline, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung

Publications (1)

Publication Number Publication Date
DD157614A5 true DD157614A5 (de) 1982-11-24

Family

ID=6098481

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81228589A DD157614A5 (de) 1980-03-27 1981-03-25 Verfahren zur herstellung von pyrimidyl-chinazolinen

Country Status (18)

Country Link
EP (1) EP0037495A1 (da)
JP (1) JPS56150088A (da)
AR (1) AR227542A1 (da)
AU (1) AU6877481A (da)
CA (1) CA1156656A (da)
CS (1) CS219898B2 (da)
DD (1) DD157614A5 (da)
DE (1) DE3011809A1 (da)
DK (1) DK115581A (da)
ES (1) ES8202000A1 (da)
FI (1) FI810778A7 (da)
GR (1) GR71870B (da)
IL (1) IL62495A0 (da)
NO (1) NO810870L (da)
PL (2) PL230320A1 (da)
PT (1) PT72724B (da)
SU (1) SU1052158A3 (da)
ZA (1) ZA812034B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140568A (ja) * 1984-12-14 1986-06-27 Mitsui Petrochem Ind Ltd キナゾリン誘導体及びそれを有効成分とする血圧降下剤
JPS6267077A (ja) * 1985-09-18 1987-03-26 Mitsui Petrochem Ind Ltd キナゾリン誘導体及び医薬
CN102079743B (zh) * 2004-03-15 2020-08-25 武田药品工业株式会社 二肽基肽酶抑制剂
US7576076B2 (en) * 2004-07-02 2009-08-18 Corcept Therapeutics, Inc. Modified pyrimidine glucocorticoid receptor modulators
CN103596431B (zh) 2011-03-18 2016-06-22 科赛普特治疗公司 嘧啶环己基糖皮质激素受体调节剂
CA3102099C (en) 2018-06-04 2023-09-26 Corcept Therapeutics Incorporated Pyrimidine cyclohexenyl glucocorticoid receptor modulators
JP7569492B2 (ja) 2019-12-11 2024-10-18 コーセプト セラピューティクス, インコーポレイテッド 抗精神病薬誘発性体重増加のミリコリラントによる治療方法
KR102911885B1 (ko) 2020-05-06 2026-01-12 코어셉트 쎄라퓨틱스 인코포레이티드 피리미딘 사이클로헥실 글루코코르티코이드 수용체 조절제의 다형체
AU2021266739B2 (en) 2020-05-06 2024-11-28 Corcept Therapeutics Incorporated Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators
JP7853982B2 (ja) 2020-12-21 2026-04-30 コーセプト セラピューティクス, インコーポレイテッド ピリミジンシクロヘキシルグルココルチコイド受容体調節因子を調製する方法
US12616698B2 (en) 2021-05-05 2026-05-05 Corcept Therapeutics Incorporated Methods for reducing liver fat and for treating fatty liver disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
SU1052158A3 (ru) 1983-10-30
PT72724B (de) 1982-03-24
ZA812034B (en) 1982-05-26
IL62495A0 (en) 1981-05-20
CS219898B2 (en) 1983-03-25
AU6877481A (en) 1981-10-01
PL233882A1 (da) 1982-05-10
DK115581A (da) 1981-09-28
FI810778L (fi) 1981-09-28
FI810778A7 (fi) 1981-09-28
EP0037495A1 (de) 1981-10-14
JPS56150088A (en) 1981-11-20
DE3011809A1 (de) 1981-10-01
ES500738A0 (es) 1982-01-16
PL230320A1 (da) 1982-03-29
ES8202000A1 (es) 1982-01-16
GR71870B (da) 1983-07-08
NO810870L (no) 1981-09-28
AR227542A1 (es) 1982-11-15
CA1156656A (en) 1983-11-08
PT72724A (de) 1981-04-01

Similar Documents

Publication Publication Date Title
DE2807392A1 (de) Neue chinazolinverbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE1545551B2 (de) 7-brom-6-halogen-3-eckige klammer auf 3-(3.hydroxy-2-piperidyl)-acetonyl eckige klammer zu-4(3h)-chinazolinone und ein verfahren zu ihrer herstellung
DE3134929A1 (de) Derivate von theophyllin und theobromin
EP0154885B1 (de) Substituierte 2-Phenyl-hexahydro-1,2,4-triazin-3,5-dione, Verfahren zu ihrer Herstellung, ihre Verwendung als Tierarzneimittel und zur Bekämpfung von Protozoen
DD211555A5 (de) Verfahren zur herstellung neuer 4-amino-6,7-dimethoxychinolin-derivate
EP0117403B1 (de) 6-(Acylaminoaryl)-3(2H)-pyridazinonderivate, ihre Herstellung und Verwendung
EP0072932A2 (de) Neue Piperazinone, ihre Herstellung und Verwendung
EP0327800B1 (de) 6-Phenyldihydro-3(2H)-pyridazinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3105330A1 (de) "4-amino-6,7-dimethoxy-2-piperazinylchinazolin-derivate, ihre herstellung und ihre verwendung"
EP0023343B1 (de) Substituierte 3-Amino-sydnonimine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE60004671T2 (de) Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung
DE2825906A1 (de) 3-(pyrazol-1'-yl)-pyridazinderivate, solche enthaltende arzneimittel und verfahren zur herstellung derselben
EP0037495A1 (de) Pyrimidyl-chinazoline, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE2819629A1 (de) Alkylendiaminderivate, verfahren zu ihrer herstellung und ihre verwendung
DE2727469A1 (de) Neue hexahydropyrimidine, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
CH664964A5 (de) Isoindolinyl-alkyl-piperazine.
DE2712023A1 (de) Sulfonamidoaminobenzoesaeurederivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
DE1620138C3 (de) Substituierte 2-Piperazino-4-amino-6,7-dimethoxychinazoline und Verfahren zu deren Herstellung
DE2424334A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
DE2427943C2 (de) Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0018360B1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung
DE3346575A1 (de) Neue benzimidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
CH637391A5 (de) Therapeutisch wirksame 3-(1-piperazinyl)-1,2,4-benzotriazine und ihre n-oxide.
EP0139993A2 (de) Chinazolinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2725019A1 (de) Verfahren zur herstellung substituierter aminochinazolinderivate und zwischenprodukte dafuer